Galeneo Health, located in Madrid, secures funding of €1 million. The largest impact investment fund for startups in Spain, the BSocial Impact Fund, was converted by the European Investment Fund, Banco Sabadell, and AXIS, with the participation of other past partners of the company. The round was led by the impact management company Ship2B Ventures.
After this funding round closes, the Galeneo team intends to boost sales across the country while improving its technology platform. its platform for innovation.
Read also – Lisburn based Cirdan Secures £2.3m in Funding
The money will be used to broaden the company’s and hospitals’ operations as well as build relationships with the public sector and the pharmaceutical business. It will also be used to streamline the B2B model for clinics and hospitals. the pharmaceutical sector.
On the other hand, they plan to keep improving their platform, facilitating interaction among the various medical staff members and healthcare providers that make up a decentralised hospital, and boosting the patient and family experience.
Jaime García-Prieto, founder and CEO of Galeneo, said: “Our mission is for a doctor to manage his patients from anywhere, guaranteeing continuity of care and the same quality that his patients have when they are quality that their patients have when they are admitted to their hospital ward.”
Jordi Ferrer, investment director of Ship2B Ventures, commented: “Galeneo is a pioneering decentralised hospitalisation project in Spain, with a great social impact at three levels: Firstly, patients can have a better recovery from the convenience and warmth of their homes. Secondly, it achieves greater reconciliation of families by avoiding visits to the hospital. Third, the hospital system increases its capacity in a cost-efficient way and without having to invest in more infrastructure.”
Long-term social and medical costs per person will rise as a result of the ageing population brought on by biomedical advancements. Patients will also become more numerous as their illnesses grow chronic. If nothing changes, this is predicted to double globally by 2050 and could surpass the GDP of certain developed nations.
About Galeno Health
Galeneo Health® is a rapidly growing startup that uses its Hospital@Home platform, which is equipped with modern technology, to coordinate on-demand and in-person delocalized medical services and operations at scale.